-
Abbott Laboratories (NYSE:ABT) Q4 2025 Earnings Call Transcript
23 Jan 2026 13:10 GMT
… amp;A Session
Follow Abbott Laboratories (NYSE:ABT) Follow Abbott Laboratories (NYSE:ABT) … are now the fastest growing generic kind segment. I feel good … a wonderful day.
Follow Abbott Laboratories (NYSE:ABT) Follow Abbott Laboratories (NYSE:ABT) Receive …
-
What You Need to Know Ahead of Abbott Laboratories' Earnings Release
26 Dec 2025 13:30 GMT
… market cap of $217 billion, Abbott Laboratories (ABT) is a healthcare company … , diagnostics, nutrition products, and branded generic pharmaceuticals. The North Chicago, Illinois …
-
2 Healthcare Dividend Stocks That are Just What the Doctor Ordered
04 Feb 2026 00:29 GMT
… patents expire and they face generic competition. Research and development is … it was spun off from Abbott Laboratories (ABT 0.36%) in 2013 …
-
UBS Reaffirms Buy Rating on Abbott Laboratories (ABT) Amid Exact Sciences Acquisition
29 Nov 2025 18:54 GMT
… cancer care with this acquisition. Abbott Laboratories (NYSE:ABT) will also add … Diagnostics, UBS is adamant that Abbott Laboratories (NYSE:ABT) will consistently outperform … a wide range of branded generic medications, medical devices, diagnostics, and …
-
Is Abbott Laboratories Stock Underperforming the S&P 500?
26 Nov 2025 11:58 GMT
… , medical devices, nutritional, and branded generic medicines.
Companies worth $200 billion … "mega-cap stocks." Abbott Laboratories fits right into that category … bearish trend.
www.barchart.com
Abbott Laboratories’ stock prices dropped 2.9% …
-
Abbott Laboratories (ABT) Rated Buy as Benchmark Highlights Diagnostics Growth and Global Resilience
21 Oct 2025 10:46 GMT
Abbott Laboratories (NYSE:ABT) ranks among … in. Benchmark began coverage of Abbott Laboratories (NYSE:ABT) on October … for any upcoming tariff talks. Abbott Laboratories (NYSE:ABT) is a … a wide range of branded generic medications, medical devices, diagnostics, …
-
HIV Therapeutics Market is expected to reach US$ 57.56 Billion by 2033 | DataM Intelligence
02 Feb 2026 11:09 GMT
… and increasing availability of affordable generic antiretroviral drugs.
Market Dynamics … in emerging economies through generic drugs and public-private …
Pfizer Inc.
Theratechnologies Inc.
Abbott Laboratories
Recent Developments:
United States:
…
-
A Look Ahead: Abbott Laboratories's Earnings Forecast
14 Oct 2025 14:20 GMT
… 00%
Performance of Abbott Laboratories Shares
Shares of Abbott Laboratories were trading at … latest insights on Abbott Laboratories.
With 10 analyst ratings, Abbott Laboratories has a … and testing kits, and branded generic drugs. Products include pacemakers, …
-
Forecasting The Future: 12 Analyst Projections For Abbott Laboratories
07 Oct 2025 19:43 GMT
… date on Abbott Laboratories analyst ratings.
Unveiling the Story Behind Abbott Laboratories
Abbott … and testing kits, and branded generic drugs. Products include pacemakers, … sales outside the United States.
Abbott Laboratories: A Financial Overview
Market …
-
Generic Oncology Drugs Market is Projected to Increase at a CAGR of 6.6% Through 2025-2029
24 Nov 2025 10:45 GMT
… towards combination therapy, precision in generic oncology medications, and broader … Myers Squibb Company
• AstraZeneca Plc
• Abbott Laboratories
• Fresenius Kabi AG
• GlaxoSmithKline PLC … .com/report/generic-oncology-drugs-global-market-report …